ARTICLE | Financial News
Coherus sets IPO terms
October 25, 2014 12:56 AM UTC
Biosimilars developer Coherus Biosciences Inc. (Redwood City, Calif.) set terms for its IPO on NASDAQ and plans to sell 6.3 million shares at $12-$15. At $13.50 Coherus would raise $85 million and be valued at $432.7 million. JPMorgan; Credit Suisse; and Cowen are underwriters. ...